Mónica Furlano

Mónica Furlano

Auto-generated profile, based on publicly available information

Mónica Furlano

Inherited Kidney Disorders, Nephrology Department, Fundacio Puigvert, Instituto de Investigaciones Biomedicas Sant Pau (IIB-Sant Pau), Universitat Autonoma de Barcelona, REDinREN, Instituto de Investigacion Carlos III, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2017 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SLSvjetlana Lovric
Svjetlana Lovric
SGSara Goncalves
Sara Goncalves
HGHeon Yung Gee
Heon Yung Gee
BOBabak Oskouian
Babak Oskouian
HSHonnappa Srinivas
Honnappa Srinivas
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt
Steroid-resistant nephrotic syndrome (SRNS) causes 15% of chronic kidney disease cases. A mutation in 1 of over 40 monogenic genes can be detected in approximately 30% of individuals with SRNS whose symptoms manifest before 25 years of age. However, in many patients, the genetic etiology remains unknown. Here, we have performed whole exome sequencing to identify recessive causes of SRNS. In 7 families with SRNS and facultative ichthyosis, adrenal insufficiency, immunodeficiency, and neurological defects, we identified 9 different recessive mutations in SGPL1, which encodes sphingosine-1-phosphate (S1P) lyase. All mutations resulted in reduced or absent SGPL1 protein and/or enzyme activity. Overexpression of cDNA representing SGPL1 mutations resulted in subcellular mislocalization of SGPL1. Furthermore, expression of WT human SGPL1 rescued growth of SGPL1-deficient dpl1Δ yeast strains, whereas expression of disease-associated variants did not. Immunofluorescence revealed SGPL1 expression in mouse podocytes and mesangial cells. Knockdown of Sgpl1 in rat mesangial cells inhibited cell migration, which was partially rescued by VPC23109, an S1P receptor antagonist. In Drosophila, Sply mutants, which lack SGPL1, displayed a phenotype reminiscent of nephrotic syndrome in nephrocytes. WT Sply, but not the disease-associated variants, rescued this phenotype. Together, these results indicate that SGPL1 mutations cause a syndromic form of SRNS.

14 August 2017 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DBDaniela Braun
Daniela Braun
JRJia Rao
Jia Rao
GMGeraldine Mollet
Geraldine Mollet
DSDavid Schapiro
David Schapiro
MDMarie-Claire Daugeron
Marie-Claire Daugeron
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt

1 August 2018 in Kidney International
Verified
Journal Article
Closed access
GBGemma Bullich
Gemma Bullich
ADAndrea Domingo-Gallego
Andrea Domingo-Gallego
IVIván Vargas
Iván Vargas
PRPatricia Ruiz
Patricia Ruiz
LLLaura Lorente-Grandoso
Laura Lorente-Grandoso
EAElisabet Ars
Elisabet Ars

1 September 2018 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
NANadia Ayasreh
Nadia Ayasreh
GBGemma Bullich
Gemma Bullich
RMRosa Miquel
Rosa Miquel
MFMónica Furlano
Mónica Furlano
PRPatricia Ruiz
Patricia Ruiz
RTRoser Torra Torra
Roser Torra Torra

12 March 2021 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
RTRoser Torra Torra
Roser Torra Torra
MFMónica Furlano
Mónica Furlano
AOAlberto Ortiz
Alberto Ortiz
EAElisabet Ars
Elisabet Ars
Inherited kidney diseases (IKDs) are among the leading causes of early-onset chronic kidney disease (CKD) and are responsible for at least 10–15% of cases of kidney replacement therapy (KRT) in adults. Paediatric nephrologists are very aware of the high prevalence of IKDs among their patients, but this is not the case for adult nephrologists. Recent publications have demonstrated that monogenic diseases account for a significant percentage of adult cases of CKD. A substantial number of these patients have received a non-specific/incorrect diagnosis or a diagnosis of CKD of unknown aetiology, which precludes correct treatment, follow-up and genetic counselling. There are a number of reasons why genetic kidney diseases are difficult to diagnose in adulthood: (i) adult nephrologists, in general, are not knowledgeable about IKDs; (ii) existence of atypical phenotypes; (iii) genetic testing is not universally available; (iv) family history is not always available or may be negative; (v) lack of knowledge of various genotype–phenotype relationships and (vi) conflicting interpretation of the pathogenicity of many sequence variants. Registries can contribute to visualize the burden of IKDs by regularly grouping all IKDs in their annual reports, as is done for glomerulonephritis or interstitial diseases, rather than reporting only cystic disease and hiding other IKDs under labels such as ‘miscellaneous’ or ‘other’. Any effort to reduce the percentage of patients needing KRT with a diagnosis of ‘nephropathy of unknown etiology’ or an unspecific/incorrect diagnosis should be encouraged as a step towards precision nephrology. Genetic testing may be of value in this context but should not be used indiscriminately, but rather on the basis of a deep knowledge of IKDs.

5 February 2024 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
MFMónica Furlano
Mónica Furlano
MTMelissa Pilco Teran
Melissa Pilco Teran
MPMarc Pybus
Marc Pybus
VMVíctor Martínez
Víctor Martínez
MAMiriam Aza-Carmona
Miriam Aza-Carmona
RTRoser Torra Torra
Roser Torra Torra
Clinical variability among individuals with heterozygous pathogenic/likely pathogenic (P/LP) variants in the COL4A3/COL4A4 genes (also called autosomal dominant Alport syndrome or COL4A3/COL4A4-related disorder) is huge; many individuals are asymptomatic or show microhematuria, while others may develop proteinuria and chronic kidney disease (CKD). The prevalence of simple kidney cysts (KC) in the general population varies according to age, and patients with advanced CKD are prone to have them. A possible association between heterozygous COL4A3, COL4A4 and COL4A5 P/LP variants and KC has been described in small cohorts. The presence of KC in a multicenter cohort of individuals with heterozygous P/LP variants in the COL4A3/COL4A4 genes is assessed in this study. We evaluated the presence of KC by ultrasound in 157 individuals with P/LP variants in COL4A3 (40.7%) or COL4A4 (53.5%) without kidney replacement therapy. The association between presence of KC and age, proteinuria, estimated glomerular filtration rate (eGFR) and causative gene was analyzed. Prevalence of KC was compared with historical case series in the general population. Half of the individuals with P/LP variants in COL4A3/COL4A4 showed KC, which is a significantly higher percentage than in the general population. Only 3.8% (6/157) had cystic nephromegaly. Age and eGFR showed an association with the presence of KC (P < .001). No association was found between KC and proteinuria, sex or causative gene. Individuals with COL4A3/COL4A4 P/LP variants are prone to develop KC more frequently than the general population, and their presence is related to age and to eGFR. Neither proteinuria, sex nor the causative gene influences the presence of KC in these individuals.